Golimumab in real-world practice in patients with ulcerative colitis: Twelve-month results

Table 2 Occupational status

	mITT (n = 282)	mITTe (n = 212)
Occupational status
Employed (full time)	172 (61.0)	172 (81.1)
Employed (part time)	39 (13.8)	39 (18.4)
Retired	13 (4.6)	1 (0.5)1
Full reduced	12 (4.3)
Not working	46 (16.3)
Part time employment due to
Ulcerative colitis	7 (17.9)	7 (17.9)
Other reason	32 (82.1)	32 (82.1)
Full reduced due to
Ulcerative colitis	8 (66.7)	N/A
Other reason	4 (33.3)	N/A

¹One subject who stated “retired” on the electronic case report form was included, because she had entries in the work productivity and activity impairment. It was assumed that this subject actually worked part-time. Data are shown as n (%). mITT: Total analysis population; mITTe: Employed analysis population; N/A: Not applicable.